Posted

Ontario Supports Virox Technologies Inc. to Help Fight COVID-19

Cover Image for Ontario Supports Virox Technologies Inc. to Help Fight COVID-19

Ontario Funds Innovative Company to Help Fight COVID-19

Investment will Protect People, Frontline Workers and Communities

NEWS

TORONTO – The Ontario government is providing Virox Technologies Inc. with $850,000 from the Ontario Together Fund to help the local manufacturer double its production of disinfectants and create jobs. The investment will assist in keeping people, frontline workers and communities safe and stop the spread of COVID-19. Virox is the first manufacturer to receive money from the Ontario Together Fund.

The announcement was made today by Vic Fedeli, Minister of Economic Development, Job Creation and Trade.

“We are looking for the best and brightest in the province to step up and provide critical goods and services in our effort to stop the spread of COVID-19,” said Minister Fedeli. “I am pleased to see an innovative disinfectant company like Virox Technologies come forward and use its made-in-Ontario advanced technology to help keep our frontline workers and communities safe.”

Virox is planning to install a high-speed manufacturing assembly line to ramp up production of its Accelerated Hydrogen Peroxide products. It is estimated that the new equipment will allow the company to produce 6,000 cases per day, which will help meet increased demand from the health care sectors and wherever disinfectants are used. The project will create 20 full- and part-time jobs and help retain 120 positions in Oakville.

“We are pleased to respond to the government’s call to action to help stop the spread of this

outbreak,” said Randy Pilon, President and CEO, Virox Technologies Inc. “We pride ourselves on

offering sustainable hydrogen-peroxide based disinfecting solutions and making products that are

safe for people, animals and the planet. By ramping up our production with new equipment and

upgrades, we will help meet the growing need in hospitals, and communities across Ontario and

Canada.”

On March 21 Premier Doug Ford launched the Ontario Together web portal appealing to Ontario’s manufacturers, entrepreneurs and innovators to provide essential supplies and equipment to support front line workers in their fight against the COVID-19 pandemic.

To support the development of proposals submitted by businesses and individuals through the Ontario Together web portal and help businesses retool their operations, the government launched the $50 million Ontario Together Fund. All submissions received through the portal are being reviewed and prioritized to focus on solutions that can respond to where the need is greatest and can be implemented quickly.

QUICK FACTS

  • The unique properties of Accelerated Hydrogen Peroxide make disinfectants that are innovative, effective and sustainable, as well as safe for use on hands, surfaces and devices. The products are used in professional settings in infection control, among health care workers, veterinarians, aestheticians and environmental services professionals.

ADDITIONAL RESOURCES

  • See how your organization can help fight COVID-19
  • Visit Ontario’s website to learn more about how the province continues to protect Ontarians

from COVID-19.

MEDIA CONTACTS

Rebecca Bozzato
Minister Fedeli’s Office

rebecca.bozzato@ontario.ca

Kwok Wong

Communications Branch

kwok.wong@ontario.ca

647-504-2774

CLICK HERE TO VIEW PDF >


Related Posts

Cover Image for Re:Preempt (Canada) efficacy against Monkeypox Virus (MPV)

Re:Preempt (Canada) efficacy against Monkeypox Virus (MPV)

To Whom it May Concern, In cases of emerging viral pathogens such as Monkeypox Virus (MPV), when there is no test that can be conducted to validate the efficacy of a disinfectant, Health Canada utilizes its policy for claims against emerging viral pathogens to determine the expected efficacy of a disinfectant against an emerging virus. […]

READ MORE
Cover Image for Re: PREempt efficacy against SARS-CoV-2, the virus which causes COVID-19 disease

Re: PREempt efficacy against SARS-CoV-2, the virus which causes COVID-19 disease

Dear Sir or Madam, In cases of emerging viral pathogens like SARS-CoV-2, the virus that causes COVID-19, when there is no test that can be conducted to validate the efficacy of a disinfectant against an emerging viral pathogen, Health Canada utilizes the Broad Spectrum Virucide claim to determine the expected efficacy of a disinfectant against […]

READ MORE